The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Papillomavirus E6 proteins
Open accessAbstract
The papillomaviruses are small DNA viruses that encode approximately eight genes, and require the host cell DNA replication machinery for their viral DNA replication. Thus papillomaviruses have evolved strategies to induce host cell DNA synthesis balanced with strategies to protect the cell from unscheduled replication. While the papillomavirus E1 and E2 genes are directly involved in viral replication by binding to and unwinding the origin of replication, the E6 and E7 proteins have auxillary functions that promote proliferation. As a consequence of disrupting the normal checkpoints that regulate cell cycle entry and progression, the E6 and E7 proteins play a key role in the oncogenic properties of human papillomaviruses with a high risk of causing anogenital cancers (HR HPVs). As a consequence, E6 and E7 of HR HPVs are invariably expressed in cervical cancers. This article will focus on the E6 protein and its numerous activities including inactivating p53, blocking apoptosis, activating telomerase, disrupting cell adhesion, polarity and epithelial differentiation, altering transcription and reducing immune recognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Giampieri, S., García‐Escudero, R., Green, J. L., & Storey, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207711 · Cited by 33
RetractedThe serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 1×
“To avoid losing critical genetic information on chromosomes and to prevent recombination at the termini, their ends are capped with repetitive telomeric DNA approximately 10–12 kb in length and proteins collectively named shelterin (de Lange, 2005).”
BackgroundA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794 · cited 1×
“The expression level of hTERT is proportionate to the enzymatic activity of telomerase in cells, and in the majority of immortalized cells and cancers hTERT is detected (Bryan and Cech, 1999; Meyerson et al., 1997; Shay and Bacchetti, 1997).”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Mammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447
(2001) · PubMed · Cited by 2,381
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
THE UBIQUITIN SYSTEM FOR PROTEIN DEGRADATION
Hershko, A., & Ciechanover, A. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.003553 · Cited by 1,410
Telomere elongation in immortal human cells without detectable telomerase activity
Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S., & Reddel, R. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00098.x · Cited by 1,279 · cited 1×
“If telomerase is not active in immortalized cells or in cancers, telomeric DNA is extended using the alternative lengthening of telomeres (ALT) pathway of homologous end joining (Bryan et al., 1995; Neumann and Reddel, 2002).”
BackgroundInduction of Apoptosis by Cancer Chemotherapy
Kaufmann, S. H., & Earnshaw, W. C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4838 · Cited by 1,266
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206 · cited 1×
“Expression of HR HPV E6 protein in concert with HR HPV E7 protein can immortalize epithelial cells in culture (Hawley-Nelson et al., 1989; Munger et al., 1989), and one critical cellular target is telomerase (Kiyono et al., 1998; Klingelhutz et al., 1996; Veldman et al., 2003).”
BackgroundSelf-citationp53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., & de Lange, T. (1999) · Science · doi:10.1126/science.283.5406.1321 · Cited by 1,086
Telomere end-replication problem and cell aging
Levy, M. Z., Allsopp, R. C., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90096-3 · Cited by 1,069
Münger, K., Phelps, W. C., Bubb, V, Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,030
Direct activation of TERT transcription by c-MYC
Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R. (1999) · Nature Genetics · doi:10.1038/6010 · Cited by 893
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879
The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.
Scheffner, M., Münger, K., Byrne, J. C., & Howley, P. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5523 · Cited by 849
p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage
Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
Hawley‐Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., & Schiller, J. T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08570.x · Cited by 733
Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D., & Berger, S. L. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00414-2 · Cited by 710 · cited 2×
“…DNA damage, p300 is known to acetylate p53, thus enhancing its ability to bind to specific DNA sequences in the promoters of p53-responsive genes, and in turn upregulating their transcription (Barlev et al., 2001; Gu and Roeder, 1997; Ito et al., 2001; Liu et al., 1999a; Yuan et al., 1999).”
BackgroundProtein Composition of Catalytically Active Human Telomerase from Immortal Cells
Cohen, S. B., Graham, M. E., Lovrecz, G. O., Bache, N., Robinson, P. J., & Reddel, R. R. (2007) · Science · doi:10.1126/science.1138596 · Cited by 669
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 660
Wang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
Kilian, A., Bowtell, D. D. L., Abud, H. E., Hime, G. R., Venter, D. J., Keese, P. K., Duncan, E. L., Reddel, R. R., & Jefferson, R. A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2011 · Cited by 585
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T.-P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 582
Bilder, D. (2004) · Genes & Development · doi:10.1101/gad.1211604 · Cited by 553
Ronco, L. V., Karpova, A. Y., Vidal, M., & Howley, P. M. (1998) · Genes & Development · doi:10.1101/gad.12.13.2061 · Cited by 544
The Human Papillomavirus E6 protein and its contribution to malignant progression
Mantovani, F., & Banks, L. (2001) · Oncogene · doi:10.1038/sj.onc.1204869 · Cited by 514
Crook, T., Vousden, K. H., & Tidy, J. A. (1991) · Cell · doi:10.1016/0092-8674(91)90529-8 · Cited by 505
Cong, Y. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.137 · Cited by 485
高倉, 正. (2002) · Medical Entomology and Zoology · Cited by 475
Triggering the Innate Antiviral Response through IRF-3 Activation
Hiscott, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700002200 · Cited by 458
Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T., & Ishibashi, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11612 · Cited by 428
A complex barcode underlies the heterogeneous response of p53 to stress
Murray-Zmijewski, F., Slee, E. A., & Lu, X. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2451 · Cited by 420
Ashcroft, M., & Vousden, K. H. (1999) · Oncogene · doi:10.1038/sj.onc.1203012 · Cited by 415
Nakagawa, S., & Huibregtse, J. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8244-8253.2000 · Cited by 382
Hasan, U. A., Bates, E., Takeshita, F., Biliato, A., Accardi, R., Bouvard, V., Mansour, M., Vincent, I., Gissmann, L., Iftner, T., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3186 · Cited by 380
The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300
Patel, D., Huang, S., Baglia, L. A., & McCance, D. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5061 · Cited by 374
Mietz, J. A., Unger, T., Huibregtse, J. M., & Howley, P. M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05608.x · Cited by 365
Lee, S. S., Weiss, R. S., & Javier, R. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6670 · Cited by 356
Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome
Cole, S. T., & Danos, O. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90343-3 · Cited by 345
Structure and function of poly(A) binding proteins
Kühn, U., & Wahle, E. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.03.008 · Cited by 323
Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins
Jackson, S., Harwood, C., Thomas, M., Banks, L., & Storey, A. (2000) · Genes & Development · doi:10.1101/gad.182100 · Cited by 319
Telomerase and the maintenance of chromosome ends
Bryan, T. M., & Cech, T. R. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80043-x · Cited by 301
Gewin, L., Myers, H., Kiyono, T., & Galloway, D. A. (2004) · Genes & Development · doi:10.1101/gad.1214704 · Cited by 277 · cited 10×
“Numerous studies have identified residues of the E6 protein that diminishes binding to E6AP (Crook et al., 1991a; Gewin et al., 2004; Liu et al., 1999b), but recently most of these mutations have been predicted to disrupt the global integrity of E6 (Nomine et al., 2006).”
BackgroundInfluentialSelf-citationLechner, M. S., Mack, D. H., Finicle, A. B., Crook, T., Vousden, K. H., & Laimins, L. A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05375.x · Cited by 273
p53 point mutation in HPV negative human cervical carcinoma cell lines.
Crook, T., Wrede, C. D., & Vousden, K. H. (1991) · PubMed · Cited by 272
The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton
Tong, X., & Howley, P. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4412 · Cited by 268
Lee, S. S., Glaunsinger, B., Mantovani, F., Banks, L., & Javier, R. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9680-9693.2000 · Cited by 268
Glaunsinger, B. A., Lee, S. S., Thomas, M., Banks, L., & Javier, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203906 · Cited by 264
Inhibition of Bak-induced apoptosis by HPV-18 E6
Thomas, M., & Banks, L. (1998) · Oncogene · doi:10.1038/sj.onc.1202223 · Cited by 241
Veldman, T., Horikawa, I., Barrett, J. C., & Schlegel, R. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4467-4472.2001 · Cited by 237
Pan, H., & Griep, A. E. (1995) · Genes & Development · doi:10.1101/gad.9.17.2157 · Cited by 234
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.775 · Cited by 233
Veldman, T., Liu, X., Yuan, H., & Schlegel, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1435900100 · Cited by 214
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation
Thomas, M., Laura, R., Hepner, K., Guccione, E., Sawyers, C., Lasky, L., & Banks, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205668 · Cited by 204
Li, X., & Coffino, P. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4509-4516.1996 · Cited by 201
Oh, S. T., Kyo, S., & Laimins, L. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5559-5566.2001 · Cited by 201
Inhibition of p53 DNA binding by human papillomavirus E6 proteins
Lechner, M. S., & Laimins, L. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4262-4273.1994 · Cited by 195
Gao, Q., Srinivasan, S., Boyer, S. N., Wazer, D. E., & Band, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.733 · Cited by 188
Filippova, M., Song, H., Connolly, J. L., Dermody, T. S., & Duerksen-Hughes, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200113200 · Cited by 186
Papillomavirus polypeptides E6 and E7 are zinc-binding proteins
Barbosa, M. S., Lowy, D. R., & Schiller, J. T. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1404-1407.1989 · Cited by 184
Kühne, C., & Banks, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34302 · Cited by 184
Telomere maintenance and cancer ? look, no telomerase
Neumann, A. A., & Reddel, R. R. (2002) · Nature reviews. Cancer · doi:10.1038/nrc929 · Cited by 182
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4918 · Cited by 182
Thomas, M. C., & Chiang, C.-M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.016 · Cited by 178
Nominé, Y., Masson, M., Charbonnier, S., Zanier, K., Ristriani, T., Deryckère, F., Sibler, A.-P., Desplancq, D., Atkinson, R. A., Weiss, E., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.024 · Cited by 177
Gross-Mesilaty, S., Reinstein, E., Bercovich, B., Tobias, K. E., Schwartz, A. L., Kahana, C., & Ciechanover, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8058 · Cited by 177
Characterization of Human hect Domain Family Members and Their Interaction with UbcH5 and UbcH7
Schwarz, S. E., Rosa, J. L., & Scheffner, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12148 · Cited by 176
Thomas, M., & Banks, L. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-6-1513 · Cited by 166
Liu, Y., Chen, J. J., Gao, Q., Dalal, S., Hong, Y., Mansur, C. P., Band, V., & Androphy, E. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7297-7307.1999 · Cited by 165
James, M. A., Lee, J. H., & Klingelhutz, A. (2006) · Journal of Virology · doi:10.1128/jvi.01942-05 · Cited by 162
Underbrink, M. P., Howie, H. L., Bedard, K. M., Koop, J. I., & Galloway, D. A. (2008) · Journal of Virology · doi:10.1128/jvi.00902-08 · Cited by 158
Self-citationGewin, L., & Galloway, D. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7198-7201.2001 · Cited by 156
Self-citationInterference of papillomavirus E6 protein with single‐strand break repair by interaction with XRCC1
Iftner, T., Elbel, M., Schopp, B., Hiller, T., Loizou, J. I., Caldecott, K. W., & Stubenrauch, F. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf443 · Cited by 152
Garnett, T. O., Filippova, M., & Duerksen-Hughes, P. J. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401886 · Cited by 152
Doorbar, J., Foo, C., Coleman, N., Medcalf, L., Hartley, O., Prospero, T. D., Napthine, S., Sterling, J. C., Winter, G. P., & Griffin, H. M. (1997) · Virology · doi:10.1006/viro.1997.8768 · Cited by 150
Filippova, M., Parkhurst, L., & Duerksen-Hughes, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401172200 · Cited by 149
McMurray, H. R., & McCance, D. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.18.9852-9861.2003 · Cited by 143
Spanos, W. C., Hoover, A. C., Harris, G. F., Wu, S., Strand, G. L., Anderson, M. E., Klingelhutz, A. J., Hendriks, W. J. A. J., Bossler, A., & Lee, J. H. (2007) · Journal of Virology · doi:10.1128/jvi.02188-07 · Cited by 139
Thomas, M., Glaunsinger, B. A., Pim, D., Javier, R., & Banks, L. (2001) · Oncogene · doi:10.1038/sj.onc.1204719 · Cited by 131
Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3
Kumar, A., Zhao, Y., Meng, G., Zeng, M., Srinivasan, S., Delmolino, L. M., Gao, Q., Dimri, G., Weber, G. F., Wazer, D. E., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5801-5812.2002 · Cited by 131
Lee, C., & Laimins, L. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12366-12377.2004 · Cited by 125
Spain, B. H., Bowdish, K. S., Pacal, A. R., Staub, S. F., Koo, D., Chang, C.-Y. R., Xie, W., & Colicelli, J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6698 · Cited by 121
Piña, B., Berger, S. L., Marcus, G. A., Silverman, N. S., Agapite, J., & Guarente, L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.5981 · Cited by 119
The G2 Checkpoint Is Maintained by Redundant Pathways
Passalaris, T. M., Benanti, J. A., Gewin, L., Kiyono, T., & Galloway, D. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5872 · Cited by 116 · cited 1×
“Prolonged proliferation in the absence of p53 can lead to the loss of the G2 checkpoint, which can result in aneuploidy (Passalaris et al., 1999).”
BackgroundSelf-citationA Human Suppressor of c-Jun N-terminal Kinase 1 Activation by Tumor Necrosis Factor α
Jin, D., Teramoto, H., Giam, C., Chun, R. F., Gutkind, J. S., & Jeang, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25816 · Cited by 112
Ming, J., Bohl, J., Brimer, N., Kinter, M. T., & Pol, S. V. (2006) · Journal of Virology · doi:10.1128/jvi.01979-06 · Cited by 112
HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6
Pim, D., & Banks, L. (1999) · Oncogene · doi:10.1038/sj.onc.1203134 · Cited by 109
Cerezo, A., Kalthoff, H., Schuermann, M., Schäfer, B., & Boukamp, P. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1305 · Cited by 107
Role for p300 in Stabilization of p53 in the Response to DNA Damage
Yuan, Z.-M., Huang, Y., Ishiko, T., Nakada, S., Utsugisawa, T., Shioya, H., Utsugisawa, Y., Yokoyama, K. K., Weichselbaum, R. R., Shi, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1883 · Cited by 107
The Arf/p53 pathway in cancer and aging
Matheu, A., Maraver, A., & Serrano, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6851 · Cited by 105
Anderson, C. J., Hoare, S. F., Ashcroft, M. A., Bilsland, A. E., & Keith, W. N. (2005) · Oncogene · doi:10.1038/sj.onc.1209011 · Cited by 104
Filippova, M., Johnson, M. M., Bautista, M., Filippov, V., Fodor, N., Tungteakkhun, S. S., Williams, K., & Duerksen-Hughes, P. J. (2007) · Journal of Virology · doi:10.1128/jvi.01924-06 · Cited by 103
Liu, X., Yuan, H., Fu, B., Disbrow, G. L., Apolinario, T., Tomaić, V., Kelley, M. L., Baker, C. C., Huibregtse, J., & Schlegel, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410343200 · Cited by 99
Lu, Z., Hu, X., Li, Y., Zheng, L., Zhou, Y., Jiang, H., Ning, T., Basang, Z., Zhang, C., & Ke, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403385200 · Cited by 96
Identification of an α Helical Motif Sufficient for Association with Papillomavirus E6
Chen, J. J., Hong, Y., Rustamzadeh, E., Baleja, J. D., & Androphy, E. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13537 · Cited by 93
Functional Interaction of a Novel Cellular Protein with the Papillomavirus E2 Transactivation Domain
Breiding, D. E., Sverdrup, F. M., Grossel, M. J., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7208 · Cited by 92
Srivenugopal, K. S., & Ali‐Osman, F. (2002) · Oncogene · doi:10.1038/sj.onc.1205762 · Cited by 92
Bedard, K., Underbrink, M. P., Howie, H. L., & Galloway, D. A. (2008) · Journal of Virology · doi:10.1128/jvi.01818-07 · Cited by 88
Self-citationAMF-1/Gps2 Binds p300 and Enhances Its Interaction with Papillomavirus E2 Proteins
Peng, Y.-C., Breiding, D. E., Sverdrup, F. M., Richard, J. G., & Androphy, E. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.5872-5879.2000 · Cited by 87
Yuan, H., Fu, F., Zhuo, J., Wang, W., Nishitani, J., An, D. S., Chen, I. S. Y., & Liu, X. (2005) · Oncogene · doi:10.1038/sj.onc.1208691 · Cited by 86
Leverrier, S., Bergamaschi, D., Ghali, L. R., Ola, A., Warnes, G., Akgũl, B., Blight, K., García‐Escudero, R., Penna, A., Eddaoudi, A., et al. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0004-1 · Cited by 83
Kukimoto, I., Aihara, S., Yoshiike, K., & Kanda, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9066 · Cited by 82
Effects of human papillomavirus type 16 oncoproteins on survivin gene expression
Borbély, Á., Murvai, M., Kónya, J., Beck, Z., Gergely, L., Li, F., & Veress, G. (2006) · Journal of General Virology · doi:10.1099/vir.0.81067-0 · Cited by 81
Oh, S., Song, Y., Kim, U.-J., Yim, J., & Kim, T. K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1366 · Cited by 80
Katzenellenbogen, R. A., Egelkrout, E. M., Vliet-Gregg, P., Gewin, L. C., Gafken, P. R., & Galloway, D. A. (2007) · Journal of Virology · doi:10.1128/jvi.02007-06 · Cited by 78
Self-citationHuman papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
Gao, Q., Kumar, A., Singh, L., Huibregtse, J. M., Beaudenon, S. L., Srinivasan, S. V., Wazer, D. E., Band, H., & Band, V. (2002) · PubMed · Cited by 76
Elston, R. C., Doorbar, J., & Napthine, S. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-2-371 · Cited by 74
Song, Z., Krishna, S., Thanos, D., Strominger, J. L., & Ono, S. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1763 · Cited by 72
Degenhardt, Y., & Silverstein, S. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11791-11802.2001 · Cited by 71
Zimmermann, H., Koh, C.-H., Degenkolbe, R., O’Connor, M. J., MÜLLER, A. E., Steger, G., Chen, J. J., Lui, Y., Androphy, E. J., & Bernard, H. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-11-2617 · Cited by 70
Zeng, M., Kumar, A., Meng, G., Gao, Q., Dimri, G. P., Wazer, D. E., Band, H., & Band, V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208447200 · Cited by 68
NFX1 Interacts with mSin3A/Histone Deacetylase To Repress hTERT Transcription in Keratinocytes
Xu, M., Luo, W., Elzi, D. J., Grandori, C., & Galloway, D. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01969-07 · Cited by 68
Self-citationStruijk, L., van der Meijden, E., Kazem, S., ter Schegget, J., de Gruijl, F. R., Steenbergen, R. D. M., & Feltkamp, M. C. W. (2008) · Journal of General Virology · doi:10.1099/vir.0.83317-0 · Cited by 65
Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent
Grm, H. Š., & Banks, L. (2004) · Journal of General Virology · doi:10.1099/vir.0.80035-0 · Cited by 64
James, M. A., Lee, J. H., & Klingelhutz, A. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22064 · Cited by 64
Gps2, a Protein Partner for Human Papillomavirus E6 Proteins
Degenhardt, Y., & Silverstein, S. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.151-160.2001 · Cited by 64
E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6
Zheng, L., Ding, H., Lu, Z., Li, Y., Pan, Y., Ning, T., & Ke, Y. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01162.x · Cited by 62
Du, J., Chen, G. G., Vlantis, A. C., Chan, P. K. S., Tsang, R. K.-Y., & van Hasselt, C. A. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.09.035 · Cited by 60
Modulation of transcriptional regulatory properties of p53 by HPV E6.
Crook, T., Fisher, C., Masterson, P. J., & Kh, V. (1994) · PubMed · Cited by 60
Steller, M. A., Zou, Z., Schiller, J. T., & Baserga, R. (1996) · PubMed · Cited by 59
Singh, L., Gao, Q., Kumar, A., Gotoh, T., Wazer, D. E., Band, H., Feig, L. A., & Band, V. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1614-1620.2003 · Cited by 57
Kuballa, P., Matentzoglu, K., & Scheffner, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m605117200 · Cited by 55
Be, X., Hong, Y., Wei, J. C., Androphy, E. J., Chen, J. J., & Baleja, J. (2001) · Biochemistry · doi:10.1021/bi0019592 · Cited by 51
Spanos, W. C., Geiger, J., Anderson, M. E., Harris, G. F., Bossler, A., Smith, R. B., Klingelhutz, A. J., & Lee, J. (2007) · Head & Neck · doi:10.1002/hed.20673 · Cited by 51
TLR9-Mediated Recognition of DNA
Müller, T. R., Hamm, S., & Bauer, S. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72167-3_3 · Cited by 49
Inhibition of E6-induced Degradation of its Cellular Substrates by Novel Blocking Peptides
Grm, H. Š., Weber, M., Elston, R., McIntosh, P. B., Griffin, H. M., Banks, L., & Doorbar, J. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.079 · Cited by 46
Mantovani, F., & Banks, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202688 · Cited by 46
Simmonds, M., & Storey, A. (2008) · International Journal of Cancer · doi:10.1002/ijc.23815 · Cited by 45
Lipari, F., McGibbon, G. A., Wardrop, E., & Cordingley, M. G. (2001) · Biochemistry · doi:10.1021/bi001837+ · Cited by 43
Binding of Human Papillomavirus Type 16 E6 to E6AP Is Not Required for Activation of hTERT
Šekaric, P., Cherry, J. J., & Androphy, E. J. (2007) · Journal of Virology · doi:10.1128/jvi.01776-07 · Cited by 42
HPV 16 E6 Blocks TNF-Mediated Apoptosis in Mouse Fibroblast LM Cells
Duerksen-Hughes, P. J., Yang, J. J., & Schwartz, S. B. (1999) · Virology · doi:10.1006/viro.1999.9977 · Cited by 40
Shamanin, V. A., Šekaric, P., & Androphy, E. J. (2008) · Journal of Virology · doi:10.1128/jvi.02466-07 · Cited by 39
Lebel, R., McDuff, F., Lavigne, P., & Grandbois, M. (2007) · Biochemistry · doi:10.1021/bi700076m · Cited by 38
Cooper, K., Herrington, C. S., Evans, M. F., Gatter, K. C., & McGee, J. O. (1993) · The Journal of Pathology · doi:10.1002/path.1711710107 · Cited by 36
Shamanin, V. A., & Androphy, E. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.2144-2152.2004 · Cited by 36
Tungteakkhun, S. S., Filippova, M., Neidigh, J. W., Fodor, N., & Duerksen-Hughes, P. J. (2008) · Journal of Virology · doi:10.1128/jvi.00538-08 · Cited by 33
αCP1 Mediates Stabilization of hTERT mRNA by Autocrine Human Growth Hormone
Emerald, B. S., Chen, Y., Zhu, T., Zhu, Z., Lee, K., Gluckman, P. D., & Lobie, P. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600224200 · Cited by 32
Ristriani, T., Nominé, Y., Masson, M., Weiss, É., & Travé, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4330 · Cited by 28
Lee, C.-H., Wooldridge, T. R., & Laimins, L. A. (2006) · Virology · doi:10.1016/j.virol.2006.08.028 · Cited by 22
(1999) · PubMed
(1989) · PubMed
(1995) · PubMed
Cited by
Human papillomavirus oncoproteins: pathways to transformation
Moody, C. A., & Laimins, L. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2886 · Cited by 1,751
Graham, S. V. (2017) · Clinical Science · doi:10.1042/cs20160786 · Cited by 456
The human papillomavirus family and its role in carcinogenesis
Tommasino, M. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.11.002 · Cited by 411
Persistence of human papillomavirus infection: keys to malignant progression
Bodily, J., & Laimins, L. A. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2010.10.002 · Cited by 339
Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology
Gheit, T. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00355 · Cited by 325
Metadata
- Authors
- Howie, H. L., Katzenellenbogen, R. A., & Galloway, D. A.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 384
- Issue
- 2
- Pages
- 324-334
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W2093710784
- Cited by
- 332
- References
- 153
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.